These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 644561)

  • 21. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostaglandins and precursors in platelet function.
    Smith JB; Ingerman CM; Silver MJ
    Ciba Found Symp; 1975; 35():207-24. PubMed ID: 776549
    [No Abstract]   [Full Text] [Related]  

  • 23. Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
    Frank P; Novak RF
    Biochem Pharmacol; 1985 Oct; 34(19):3609-14. PubMed ID: 3863620
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between the inhibitory activity on 'RCS' and prostaglandins synthesis and the anti-inflammatory activity of ketoprofen and several other non-steroidal anti-inflammatory agents.
    Guyonnet JC; Julou L
    Rheumatol Rehabil; 1976; Suppl():11-4. PubMed ID: 1013579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prostaglandin synthesis inhibitors on basal and CO2-stimulated cerebral blood flow in man.
    Eriksson S; Hagenfeldt L; Law D; Patrono C; Pinca E; Wennmalm A
    Gen Pharmacol; 1983; 14(1):179-80. PubMed ID: 6402414
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative effects of sulfinpyrazone and ibuprofen on canine platelet function and prostaglandin-mediated coronary vasodilation.
    Goldstein RE; Davenport NJ; Capurro NL; Lipson LC; Bonow RO; Shulman NR; Epstein SE
    J Cardiovasc Pharmacol; 1980; 2(4):399-409. PubMed ID: 6156338
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: Why aspirin?
    Majerus PW
    Circulation; 1976 Sep; 54(3):357-9. PubMed ID: 947566
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible acylation and inhibition of aggregation of platelets by substituted maleic anhydrides.
    Walder JA; Hyman BT; Heller MJ; Shishido RY; Klotz IM
    Mol Pharmacol; 1977 May; 13(3):407-14. PubMed ID: 406514
    [No Abstract]   [Full Text] [Related]  

  • 32. Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.
    MacIntyre DE; Gordon JL
    Thromb Res; 1977 Dec; 11(6):705-13. PubMed ID: 203057
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans.
    Cronberg S; Wallmark E; Söderberg I
    Scand J Haematol; 1984 Aug; 33(2):155-9. PubMed ID: 6474093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prostaglandin F2a on aggregation of canine platelets.
    Longenecker GL
    Thromb Res; 1980 May 1-15; 18(3-4):369-74. PubMed ID: 7414536
    [No Abstract]   [Full Text] [Related]  

  • 35. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of prostaglandins during the aggregation of human blood platelets.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1973 Apr; 52(4):965-9. PubMed ID: 4693658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in the platelet response to aspirin.
    Coppe D; Wessinger SJ; Ransil BJ; Harris W; Salzman E
    Thromb Res; 1981 Jul 1-15; 23(1-2):1-21. PubMed ID: 7302916
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets.
    O'Barr TP; Swanson EW; Fitzpatrick JE; Corby DG
    J Lab Clin Med; 1989 Nov; 114(5):575-8. PubMed ID: 2553835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.